These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 35272023)

  • 1. Striatal synaptic adaptations in Parkinson's disease.
    Shen W; Zhai S; Surmeier DJ
    Neurobiol Dis; 2022 Jun; 167():105686. PubMed ID: 35272023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopaminergic modulation of striatal function and Parkinson's disease.
    Zhai S; Shen W; Graves SM; Surmeier DJ
    J Neural Transm (Vienna); 2019 Apr; 126(4):411-422. PubMed ID: 30937538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine regulates spine density in striatal projection neurons in a concentration-dependent manner.
    Alberquilla S; Gonzalez-Granillo A; Martín ED; Moratalla R
    Neurobiol Dis; 2020 Feb; 134():104666. PubMed ID: 31682992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Synaptic Remodeling by Dopamine in Direct and Indirect Striatal Projection Neurons in Pitx3
    Suarez LM; Alberquilla S; García-Montes JR; Moratalla R
    J Neurosci; 2018 Apr; 38(15):3619-3630. PubMed ID: 29483281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa Causes Striatal Cholinergic Interneuron Burst-Pause Activity in Parkinsonian Mice.
    Paz RM; Tubert C; Stahl AM; Amarillo Y; Rela L; Murer MG
    Mov Disord; 2021 Jul; 36(7):1578-1591. PubMed ID: 33547844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular adaptations of striatal spiny projection neurons during levodopa-induced dyskinesia.
    Heiman M; Heilbut A; Francardo V; Kulicke R; Fenster RJ; Kolaczyk ED; Mesirov JP; Surmeier DJ; Cenci MA; Greengard P
    Proc Natl Acad Sci U S A; 2014 Mar; 111(12):4578-83. PubMed ID: 24599591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.
    Rubi L; Fritschy JM
    J Neurophysiol; 2020 Apr; 123(4):1496-1503. PubMed ID: 32159408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA receptor GluN2D subunit participates to levodopa-induced dyskinesia pathophysiology.
    Mellone M; Zianni E; Stanic J; Campanelli F; Marino G; Ghiglieri V; Longhi A; Thiolat ML; Li Q; Calabresi P; Bezard E; Picconi B; Di Luca M; Gardoni F
    Neurobiol Dis; 2019 Jan; 121():338-349. PubMed ID: 30261285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal cholinergic interneurons and Parkinson's disease.
    Tanimura A; Pancani T; Lim SAO; Tubert C; Melendez AE; Shen W; Surmeier DJ
    Eur J Neurosci; 2018 May; 47(10):1148-1158. PubMed ID: 28677242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The striatal cholinergic system in L-dopa-induced dyskinesias.
    Perez XA; Bordia T; Quik M
    J Neural Transm (Vienna); 2018 Aug; 125(8):1251-1262. PubMed ID: 29492663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson's Disease Models.
    Tanimura A; Du Y; Kondapalli J; Wokosin DL; Surmeier DJ
    Neuron; 2019 Feb; 101(3):444-458.e6. PubMed ID: 30658860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal plasticity in Parkinson's disease and L-dopa induced dyskinesia.
    Iravani MM; McCreary AC; Jenner P
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S123-5. PubMed ID: 22166408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Koski SK; Leino S; Panula P; Rannanpää S; Salminen O
    Neurosci Lett; 2020 Jun; 729():134932. PubMed ID: 32224226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D1/D5 Inverse Agonists Restore Striatal Cholinergic Interneuron Physiology in Dyskinetic Mice.
    Paz RM; Stahl AM; Rela L; Murer MG; Tubert C
    Mov Disord; 2022 Aug; 37(8):1693-1706. PubMed ID: 35535012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease.
    Morales I; Sabate M; Rodriguez M
    Eur J Neurosci; 2013 Jul; 38(1):2172-82. PubMed ID: 23565852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactive Response of Direct Pathway Striatal Projection Neurons to L-dopa and D1 Agonism in Freely Moving Parkinsonian Mice.
    Sagot B; Li L; Zhou FM
    Front Neural Circuits; 2018; 12():57. PubMed ID: 30104963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias.
    Bordia T; Perez XA
    Eur J Neurosci; 2019 Mar; 49(6):859-868. PubMed ID: 29923650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-DOPA Oppositely Regulates Synaptic Strength and Spine Morphology in D1 and D2 Striatal Projection Neurons in Dyskinesia.
    Suarez LM; Solis O; Aguado C; Lujan R; Moratalla R
    Cereb Cortex; 2016 Oct; 26(11):4253-4264. PubMed ID: 27613437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.